Strata Critical Medical Statistics
Total Valuation
SRTA has a market cap or net worth of $407.30 million. The enterprise value is $369.28 million.
Important Dates
The last earnings date was Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTA has 89.32 million shares outstanding. The number of shares has increased by 6.93% in one year.
| Current Share Class | 89.32M |
| Shares Outstanding | 89.32M |
| Shares Change (YoY) | +6.93% |
| Shares Change (QoQ) | +2.39% |
| Owned by Insiders (%) | 14.14% |
| Owned by Institutions (%) | 52.34% |
| Float | 59.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 79.30 |
| PS Ratio | 1.45 |
| Forward PS | 1.28 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 3.52 |
| P/FCF Ratio | 505.33 |
| P/OCF Ratio | 37.98 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 42.06, with an EV/FCF ratio of 458.16.
| EV / Earnings | n/a |
| EV / Sales | 1.32 |
| EV / EBITDA | 42.06 |
| EV / EBIT | n/a |
| EV / FCF | 458.16 |
Financial Position
The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.77 |
| Quick Ratio | 1.87 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 4.50 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.55% and return on invested capital (ROIC) is -2.89%.
| Return on Equity (ROE) | -7.55% |
| Return on Assets (ROA) | -7.47% |
| Return on Invested Capital (ROIC) | -2.89% |
| Return on Capital Employed (ROCE) | -4.62% |
| Weighted Average Cost of Capital (WACC) | 18.17% |
| Revenue Per Employee | $858,587 |
| Profits Per Employee | -$75,872 |
| Employee Count | 327 |
| Asset Turnover | 0.85 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.06% in the last 52 weeks. The beta is 2.56, so SRTA's price volatility has been higher than the market average.
| Beta (5Y) | 2.56 |
| 52-Week Price Change | +8.06% |
| 50-Day Moving Average | 5.00 |
| 200-Day Moving Average | 5.11 |
| Relative Strength Index (RSI) | 38.32 |
| Average Volume (20 Days) | 1,319,706 |
Short Selling Information
The latest short interest is 4.55 million, so 5.09% of the outstanding shares have been sold short.
| Short Interest | 4.55M |
| Short Previous Month | 4.54M |
| Short % of Shares Out | 5.09% |
| Short % of Float | 7.69% |
| Short Ratio (days to cover) | 4.98 |
Income Statement
In the last 12 months, SRTA had revenue of $280.76 million and -$24.81 million in losses. Loss per share was -$0.29.
| Revenue | 280.76M |
| Gross Profit | 60.56M |
| Operating Income | -13.12M |
| Pretax Income | -21.12M |
| Net Income | -24.81M |
| EBITDA | 8.78M |
| EBIT | -13.12M |
| Loss Per Share | -$0.29 |
Full Income Statement Balance Sheet
The company has $41.64 million in cash and $3.62 million in debt, with a net cash position of $38.02 million or $0.43 per share.
| Cash & Cash Equivalents | 41.64M |
| Total Debt | 3.62M |
| Net Cash | 38.02M |
| Net Cash Per Share | $0.43 |
| Equity (Book Value) | 276.38M |
| Book Value Per Share | 3.09 |
| Working Capital | 80.02M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $10.72 million and capital expenditures -$9.92 million, giving a free cash flow of $806,000.
| Operating Cash Flow | 10.72M |
| Capital Expenditures | -9.92M |
| Depreciation & Amortization | 21.90M |
| Net Borrowing | n/a |
| Free Cash Flow | 806,000 |
| FCF Per Share | $0.01 |
Full Cash Flow Statement Margins
Gross margin is 21.57%, with operating and profit margins of -4.67% and -8.84%.
| Gross Margin | 21.57% |
| Operating Margin | -4.67% |
| Pretax Margin | -7.52% |
| Profit Margin | -8.84% |
| EBITDA Margin | 3.13% |
| EBIT Margin | -4.67% |
| FCF Margin | 0.29% |
Dividends & Yields
SRTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -6.93% |
| Shareholder Yield | -6.93% |
| Earnings Yield | -6.32% |
| FCF Yield | 0.20% |
Analyst Forecast
The average price target for SRTA is $9.63, which is 111.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.63 |
| Price Target Difference | 111.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 17.28% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTA has an Altman Z-Score of 5.37 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.37 |
| Piotroski F-Score | 4 |